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ARTICLE
A multivariable Mendelian randomization analysis
investigating smoking and alcohol consumption
in oral and oropharyngeal cancer
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The independent effects of smoking and alcohol in head and neck cancer are not clear, given
the strong association between these risk factors. Their apparent synergistic effect reported
in previous observational studies may also underestimate independent effects. Here we
report multivariable Mendelian randomization performed in a two-sample approach using
summary data on 6,034 oral/oropharyngeal cases and 6,585 controls from a recent genome-
wide association study. Our results demonstrate strong evidence for an independent causal
effect of smoking on oral/oropharyngeal cancer (IVW OR 2.6, 95% CI= 1.7, 3.9 per standard
deviation increase in lifetime smoking behaviour) and an independent causal effect of alcohol
consumption when controlling for smoking (IVW OR 2.1, 95% CI= 1.1, 3.8 per standard
deviation increase in drinks consumed per week). This suggests the possibility that the causal
effect of alcohol may have been underestimated. However, the extent to which alcohol is
modified by smoking requires further investigation.
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Head and neck squamous cell carcinoma (HNSCC), whichincludes cancers of the oral cavity and oropharynx, is theworld’s 6th most common cancer1. Prognosis remains
poor, with survival ranging between 19 and 59% at 10 years2.
Established risk factors include cigarette smoking and alcohol
intake, as well as the human papilloma virus (HPV), which is
mainly linked with oropharyngeal cases and thought to be sexually
transmitted3–5. While a large proportion of cases of head and neck
cancer are attributable to the combination of smoking and alcohol,
the respective contribution of these risk factors is not clear given
the strong association between these behaviours. Better estimation
of the known risk effects may help identify or clarify the impor-
tance of other potential risk factors. One large pooled analysis6
from 17 European and American case-control studies (11,221
cases and 16,168 controls) found that, of the population attribu-
table risk of smoking and alcohol, 4% could be attributed to
alcohol alone and 33% to tobacco alone, with 35% explained by a
greater than multiplicative joint effect of alcohol and tobacco
combined for oral and oropharyngeal cancer. However, the
apparent synergistic effect seen in observational studies may
underestimate the independent effects of smoking and alcohol.
Mendelian randomisation (MR) is an approach which attempts
to minimise issues of measurement error, reverse causation and
confounding by using genetic variants which are randomly dis-
tributed at birth and are known to be reliably associated with
modifiable risk factors of interest, to obtain causal effect estimates
for these risk factors on disease outcomes7,8. To thoroughly
evaluate the causal effects of both alcohol consumption and
smoking on the risk of oral and oropharyngeal cancer, we first
conducted univariable MR analysis. A recent genome-wide
association study (GWAS) reported a genetic correlation (rg
~0.34, 95% CI= 0.3, 0.4, p= 6.7 × 10−63) between alcohol use
and smoking initiation, suggesting that sequence variations
overlap substantially and that there is a causal pathway operating
between them9. To account for this correlation between smoking
and alcohol, and to simultaneously investigate the independent
effects of each, we conducted multivariable Mendelian
randomisation10,11. As well as investigating the effects of smoking
initiation, we aimed to capture a quantitative lifetime measure of
smoking behaviour using the comprehensive smoking index
(CSI). This was used to compare the independent causal effect of
smoking with the continuous measure of alcoholic drinks per
week12. Finally, given evidence of strong genetic correlation for
both smoking and alcohol intake with other risky behaviours13,
and the established link between sexual behaviour and HPV-
driven head and neck cancer14, we conducted additional MR
analysis of both risk tolerance and lifetime number of sexual
partners on oral cavity (OC) and oropharyngeal cancer (OPC).
In this work we use multivariable MR to demonstrate strong
evidence for an independent causal effect of both smoking and
alcohol consumption on oral and oropharyngeal cancer. This
suggests the possibility that the effect of alcohol may have been
previously underestimated. However, the extent to which alcohol
is modified by smoking requires further investigation.
Results
Univariable Mendelian randomisation. Using 176 single
nucleotide polymorphisms (SNPs) robustly and independently
associated with smoking initiation (Supplementary Data 1), uni-
variable MR provided strong evidence that smoking increases risk
of oral/ oropharyngeal cancer (IVW Odds Ratio (OR) 2.5, 95%
CI= 1.6, 3.9, p= 6.94 × 10−5 per log odds of smoking) (Table 1,
Supplementary Figs. 1, 2). The direction of effect was consistent
across the four MR methods tested (IVW, weighted median,
weighted mode and MR-Egger), although MR-Egger results had
wider confidence intervals (CI) and were less reliable due to low
I2 values of the SNP-exposure associations, indicating possible
violation of the no measurement error (NOME) assumption
(Supplementary Table 1). There was some evidence of hetero-
geneity in the SNP effects (Supplementary Table 2) although no
SNP effect outliers were detected from MR-PRESSO and MR-
Egger intercepts indicated limited evidence of directional pleio-
tropy (Supplementary Table 3). Effects were consistent, and ORs
slightly larger, when the summary statistics for smoking initiation
were obtained from a GWAS meta-analysis in GSCAN which
excluded 23andMe and UK Biobank (IVW OR 3.3, 95% CI= 1.8,
6.1) and a GWAS conducted in the UK Biobank only (IVW OR
5.2, 95% CI= 1.8, 14.9) (Table 1).
Findings of a causal effect of smoking initiation on oral and
oropharyngeal cancer risk were further supported by MR analysis
using 108 SNPs associated with a lifetime measure of smoking
behaviour, the comprehensive smoking index (CSI) (Supplemen-
tary Data 1). Here, a 1 standard deviation (SD) increase in the CSI
(equivalent to an individual smoking 20 cigarettes a day for 15
years and stopping 17 years ago, or an individual smoking 60
cigarettes a day for 13 years and stopping 22 years ago) was found
to increase oral and oropharyngeal cancer risk combined, with an
IVW OR of 3.5 (95% CI= 2.4, 5.0, p= 5.97 × 10−11) (Table 1,
Supplementary Figs. 3, 4, Supplementary Tables 1–3).
Using 60 SNPs robustly and independently associated with
number of alcoholic drinks per week, univariable MR provided
strong evidence that increased alcohol consumption increases risk
of oral/oropharyngeal cancer. Here a 1 SD increase in drinks per
week (equivalent to 9 additional drinks per week) was found to
increase oral and oropharyngeal cancer risk combined, with an
IVW OR of 10.0 (95% CI= 5.3, 18.6, p= 5.64 × 10−13) (Table 2).
The direction of effect was consistent across the four MR methods
tested and high I2 values of the SNP-exposure associations
indicated low bias from regression dilution (i.e., attenuation
towards the null of an association as a result of random
measurement error) (Supplementary Table 1). However, there
was some heterogeneity in the SNP effect estimates (Supplemen-
tary Table 2) and MR-Egger intercepts indicated some evidence
for directional pleiotropy (Supplementary Table 3). Effects were
consistent, although ORs slightly smaller, when the summary
statistics for drinks per week were obtained from a GWAS meta-
analysis in GSCAN which excluded 23andMe and UK Biobank
(IVW OR 8.3, 95% CI= 4.7, 14.4) and a GWAS conducted in the
UK Biobank only (IVW OR 5.8, 95% CI= 3.7, 9.0) (Table 1). In
the main analysis, MR-PRESSO identified an influential outlier
which was the ADH1B variant, rs1229984 (outlier test p-value=
0.024) which was also shown to be a clear outlier in both scatter
and leave-one-out plots (Fig. 1). With removal of this outlier, the
causal effect estimate was halved but still large (OR 4.5, 95% CI=
2.3, 9.0). The MR-Egger intercept indicated no further directional
pleiotropy once this variant was removed (Supplementary
Table 3).
Stratification by cancer subsite. In MR analysis stratified by
cancer subsite, we found evidence for a causal effect of smoking
initiation in both oral cavity (IVW OR 2.0, 95% CI= 1.2, 3.4) and
oropharyngeal cancer (IVW OR 2.8, 95% CI= 1.6, 4.9); com-
prehensive smoking index in OC (IVW 2.6, 95% CI= 1.6, 4.3)
and OPC (IVW 4.0, 95% CI= 2.5, 6.5); and alcoholic drinks per
week in OC (IVW OR 5.9, 95% CI 2.4, 14.2) and OPC (IVW OR
3.3, 95% CI= 1.3, 8.1), which were consistent across the MR
methods (Fig. 2).
Multivariable Mendelian randomisation. In the multivariable
MR analysis controlling for alcohol consumption, there was
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strong evidence for a direct causal effect of lifetime smoking
behaviour on risk of oral/oropharyngeal cancer (IVW OR 2.6,
95% CI= 1.7, 3.9 per SD increase in the CSI) (Table 3). In
multivariable MR analysis controlling for lifetime smoking,
there was also strong evidence for a direct causal effect of
alcohol consumption on risk of oral/oropharyngeal cancer
(IVW OR 5.2, 95% CI= 3.2, 8.6 per SD increase in drinks per
week) (Table 3). The independent causal effects estimated from
multivariable MR-Egger were consistent with the IVW analysis
for both alcohol consumption and lifetime smoking (Table 3).
While there was limited evidence for heterogeneity in the SNP
effect estimates indicating instrument validity, the MR-Egger
intercept deviated from the null, which is suggestive of direc-
tional pleiotropy. When we removed the ADH1B variant found
Table 1 Univariable Mendelian randomisation of smoking and risk of oral and oropharyngeal cancer.
Exposure Exposure dataset Exposure N N SNPs F-stat Method OR 95% CI P
Smoking initiation† GSCAN 1,232,091 176 39.9 IVW* 2.50 1.59, 3.91 6.94E−5
Weighted median 2.72 1.46, 5.05 0.001
Weighted mode 6.84 1.00, 46.78 0.052
MR-Egger** 5.34 0.47, 58.7 0.181
MR-PRESSO NA NA NA
Smoking initiation† GSCAN without UK
Biobank***
249,171 176 8.71 IVW* 3.33 1.81, 6.13 1.16E−4
Weighted median 2.52 1.08, 5.85 0.032
Weighted mode 3.38 0.54, 21.1 0.195
MR-Egger** 4.8 0.57, 40.0 0.149
MR-PRESSO NA NA NA
Smoking initiation† UK Biobank 461,066 176 18.4 IVW* 5.20 1.80, 14.9 0.002
Weighted median 2.62 0.58, 11.9 0.213
Weighted mode 0.77 0.06, 10.1 0.590
MR-Egger** 0.37 0.01, 10.7 0.563
MR-PRESSO NA NA NA
Comprehensive
smoking index‡
UK Biobank 462,690 108 45.2 IVW* 3.47 2.39, 5.03 5.97E−11
Weighted median 3.45 1.96, 6.08 1.84E-5
Weighted mode 3.38 0.87, 13.4 0.085
MR-Egger** 3.16 0.40, 24.9 0.279
MR-PRESSO NA NA NA
All statistical tests were two-sided.
F-stat mean F-statistic, IVW inverse variance weighted, OR odds ratio, CI confidence intervals, P p-value, NA if no outliers detected.
*Random effects model.
**SIMEX given low I2 value, should be interpreted with caution.
†per log odds of smoking initiation.
‡per SD increase in Comprehensive Smoking Index.
***Also excludes 23andMe study.
Table 2 Univariable Mendelian randomisation of alcohol consumption and risk of oral and oropharyngeal cancer.
Exposure Exposure dataset Exposure N N SNPs F-stat Method OR 95% CI P
Drinks per week☨ GSCAN 941,280 60 74.7 IVW* 9.96 5.33, 18.6 5.64E−13
Weighted median 30.0 12.6, 71.5 1.47E−14
Weighted mode 40.4 15.72, 103.8 1.88E−10
MR-Egger 36.7 14.1, 95.5 6.80E−10
MR-PRESSO 4.50 2.26, 8.96 7.12E−5
GSCAN without UK Biobank*** 226,223 60 17.1 IVW* 8.25 4.74, 14.4 8.04E−14
Weighted median 19.4 98.9, 42.1 5.09E−14
Weighted mode 17.1 7.69, 37.8 2.92E−9
MR-Egger 16.4 7.47, 36.0 3.27E−9
MR-PRESSO NA NA NA
UK Biobank 414,343 60 49.0 IVW* 5.80 3.70, 9.01 1.54E−14
Weighted median 12.4 6.79, 22.7 3.04E−16
Weighted mode 11.3 6.25, 20.4 5.09E−11
MR-Egger 9.83 5.26, 18.4 1.55E−9
MR-PRESSO NA NA NA
All statistical tests were two-sided.
F-stat mean F-statistic, IVW inverse variance weighted; OR odds ratio, CI confidence intervals, P p-value, NA if no outliers detected.
*Random effects model.
☨per SD increase in drinks per week
***Also excludes 23andMe study.
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to be an outlier in the univariable MR analysis, the independent
effects of both smoking and alcohol on risk of oral/orophar-
yngeal cancer persisted remained, although the magnitude of
the effect was reduced for alcohol (IVW OR 2.1, 95% CI= 1.1,
3.8) (Table 3, Fig. 3). The MR-Egger intercept indicated no
further directional pleiotropy once this variant was removed
(Supplementary Table 3).
In multivariable MR analysis stratified by cancer subsite, we
found evidence for a causal independent effect of lifetime
smoking in OC (IVW OR 2.5, 95% CI= 1.5, 4.1) and OPC
(IVW 3.7, 95% CI= 2.3, 6.0); and for alcoholic drinks per week in
OC (IVW OR 2.2, 95% CI= 1.0, 5.0) and OPC (IVW OR 1.9,
95% CI= 0.9, 4.0) (Fig. 3).
Investigating other risky behaviours. We found limited evidence
to suggest there is a causal effect of risk tolerance more generally
on risk of oral and oropharyngeal cancer (IVW OR 1.0, 95%
CI= 0.6, 1.7 per SD) which was consistent across the MR
methods applied (Fig. 4). There was some evidence for a causal
effect of lifetime number of sexual partners (IVW OR 1.5, 95%
CI= 1.0, 2.3 per SD), which was specific to oropharyngeal (IVW

































































































MR leave−one−out sensitivity analysis for
’drinks per week’ on ’oral/oropharyngeal cancer’
Fig. 1 Scatter and leave one out plots demonstrating influential outliers in univariable MR of alcohol consumption and oral and oropharyngeal
cancer risk. a Scatter plot showing ADH1B (rs1229984), an outlier single nucleotide polymorphism in the analysis of alcohol consumption (drinks per
week, n= 941,280) and oral and oropharyngeal cancer risk (n= 6034 cases and 6585 controls). b Leave one out plot again demonstrating the
ADH1B (rs1229984) influential outlier. Consistent evidence for a causal effect of alcohol on oral and oropharyngeal cancer risk was found even when
this variant was excluded from the analysis. Effect estimates are reported per SD increase in the exposure and error bars represent 95% confidence
intervals.
Inverse variance weighted
Smoking initiationa b cComprehensive smoking index
Cancer OC OPC OC+OPC
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Fig. 2 Univariable Mendelian randomisation of smoking initiation, lifetime smoke exposure and drinks per week on oral and oropharyngeal cancer
subsites. Univariable effects displayed were obtained using summary-level data from the GWAS of (a) smoking initiation (n= 1,232,091), (b)
comprehensive smoking index (n= 462,690) and (c) drinks per week (n= 941,280) on oral and oropharyngeal cancer risk (n= 6034 cases and 6585
controls). Smoking initiation estimates are reported per log odds increase, while comprehensive smoking index and drinks per week are reported per SD
increase in drinks per week. Error bars represent 95% confidence intervals. All statistical tests were two-sided.
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risk (IVW OR 1.2, 95% CI= 0.7, 2.0), and reasonably consistent
across the MR methods applied (Fig. 4).
Discussion
In this study, we applied both univariable and multivariable
Mendelian Randomisation to determine a causal, independent
effect of both smoking and alcohol consumption on the risk of
oral and oropharyngeal cancer. The results were largely robust to
sensitivity analyses accounting for horizontal pleiotropy. Effects
were consistent between both oral cavity and oropharyngeal
subsites and unlikely to be strongly influenced by risk tolerance
and lifetime number of sexual partners.
Supporting of our findings regarding an independent effect of
smoking, average relative risks (RR) of reported tobacco smoking
have been found to range from 4.0–5.0 for both the oral cavity
and oropharynx across 16 case-control and 3 cohort studies15.
Alcohol use has been associated with an increased risk of oral and
oropharyngeal cancer in a dose-dependent manner (RR 1.1 (95%
CI= 1.0, 1.3) for light drinking to RR 5.1 (95% CI= 4.3, 6.1) for
heavy drinking (>50 g alcohol per day)16. Hashibe et al6. inves-
tigated the independent effects of smoking and alcohol and found
an OR of 2.4 (95% CI= 1.7, 3.4) for ever tobacco use among
never alcohol drinkers and a more than multiplicative joint effect
of tobacco and alcohol, but no clear effect of ever alcohol use
among never tobacco users (OR 1.1, 95% CI= 0.9, 1.3), sug-
gesting that alcohol use on its own may not play an important
role6. Limitations of observational studies include recall bias,
differential measurement error, as well as potential residual
confounding, for example by socio-economic position, HPV
status17 and other lifestyle factors18–20.
The independent effect for alcohol in our study suggests the
possibility that previous observational estimates for alcohol may
have been underestimated, but these cannot be directly compared
given the differences in the methodological approaches and
interpretation of estimates. MR estimates may reflect the effects of
lifelong alcohol exposure, in comparison to the short-term effects
captured in observational studies. Furthermore, while multivariable
MR can estimate the independent (and unconfounded) effect of
alcohol on oral/oropharyngeal cancer risk, it cannot determine the
extent to which this effect is modified by smoking status, i.e., is it
observed among smokers only or the whole population. Further
individual level data analysis is required to determine this.
Several mechanisms have been suggested to explain the observed
associations between alcohol and risk of head and neck cancer,
including contaminants present in alcoholic drinks (e.g., N-
nitrosodiethylamine in beer)21, free radical damage and impair-
ment of DNA repair capacity22,23. Ethanol is oxidised to acet-
aldehyde, which has a direct carcinogenic effect and moreover
alcohol may act as a ‘solvent’ for tobacco carcinogens and the
induction of carcinogen-metabolising enzymes24,25. Given their
strong co-existence, the effects of smoking and alcohol are often
difficult to separate out. However, in addition to the reported
synergistic effect, previous observational data has highlighted an
independent effect of both agents26, with our results supporting this.
Studies which have used genetic variation in alcohol-
metabolising genes do give some support to our findings. For
example, East Asians who are homozygous for the (*2*2) variant
allele of ALDH2 (aldehyde dehydrogenase 2) are unable to
metabolise acetaldehyde, which deters them from drinking alco-
hol, whereas those who are heterozygous (*1*2) have a 6-fold
higher blood acetaldehyde concentration post-alcohol consump-
tion with respect to the wild type *1*1. The OR of HNSCC
among individuals with *2*2 has been found to be 0.5 (95% CI=
0.3, 1.0) and 1.8 (95% CI= 1.2, 2.8) among those with *1*2,
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Fig. 3 Multivariable Mendelian randomisation of lifetime smoke exposure and drinks per week on oral and oropharyngeal subsites. Effect
estimates (ORs) are reported per SD increase in the exposure of drinks per week (n= 226,223) and the comprehensive smoking index (n= 226,223) on
oral and oropharyngeal cancer risk (n= 6034 cases and 6585 controls). Error bars represent 95% confidence intervals. Genetic instrument for drinks per
week excludes outlying variant, ADH1B (rs1229984). Univariable and multivariable effects displayed were obtained using summary-level data from the
GWAS of comprehensive smoking index in UK Biobank and summary-level data from a GWAS of drinks per week in GSCAN, excluding UK Biobank and


















Risk tolerancea b Number of sexual partners
-2 0 2 4
Effect (95% Cl)
-2 0 2
Cancer OC OPC OC+OPC
Fig. 4 Univariable Mendelian randomisation of risk tolerance and number of sexual partners on oral and oropharyngeal cancer subsites. Effect
estimates (log odds) are reported per SD increase in (a) risk tolerance (n= 508,782) and (b) number of sexual partners (n= 370,711). There was some
evidence for a causal effect of number of sexual partners specific to the oropharyngeal subsite. Error bars represent 95% confidence intervals. All statistical
tests were two-sided.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-19822-6
6 NATURE COMMUNICATIONS |         (2020) 11:6071 | https://doi.org/10.1038/s41467-020-19822-6 | www.nature.com/naturecommunications
that alcohol increases HNSCC risk given the protective effect of
non-drinking among homozygous individuals, while also indi-
cating the carcinogenic action of acetaldehyde27. While the fre-
quency of the *2 variant of ALDH2 in non-Eastern populations is
low, a recent GWAS revealed variation at other sites in the
genome which are linked with alcohol consumption9. An MR
analysis using these multiple variants robustly associated with
alcohol from this recent GWAS9, demonstrated a causal effect of
alcohol intake on HNSCC (OR 3.9, 95% CI= 1.3, 11.2) in the UK
Biobank, although there were only 856 HNSCC cases included in
this cohort28. A more recent multivariable MR study in UK
Biobank29 investigated smoking initiation and alcohol con-
sumption with multiple cancers. This study demonstrated that
smoking initiation increased odds of head and neck cancer when
adjusted for alcohol (IVW OR 1.4, 95% CI= 1.1, 1.8, p= 0.002).
There was also a strong positive effect of alcohol consumption on
head and neck cancer risk when adjusted for smoking (IVW OR
1.9, 95% CI= 0.8, 4.6, p= 0.142), although with wider confidence
intervals29.
The current study applied both univariable and multivariable
MR methods, using the largest number of SNPs identified from
the latest GWAS for both smoking9,12, alcohol consumption9,13
and head and neck cancer30, that could be identified in the lit-
erature. A series of pleiotropy-robust MR methods and outlier
detection were applied to rigorously explore the possibility that
findings were not biased as a result of pleiotropy. Comparability
of smoking initiation and alcohol consumption is an issue given
that alcohol consumption is closer to a measure of lifetime use,
whereas smoking initiation captures both light and short-term
smokers and heavy, long-term smokers. To account for this and
to evaluate the causal effects of a quantitative measure of smoke
exposure, we performed univariable and multivariable MR using
genetic variants identified in relation to a CSI12.
The effect of smoking and alcohol on HNSCC risk is thought
to be synergistic, with their combined use interacting in a mul-
tiplicative manner31. We were not able to investigate this here as
MR interaction analysis relies on individual-level data which we
did not have access to32. We were also unable to investigate the
potential carcinogenic role of acetaldehyde, distinct from alcohol
intake, as has been done previously using alcohol dehydrogenase
genotypes27,33, as this again typically relies on individual-level
data to assess gene-by-environment interactions. Our finding that
the ADH1B variant, rs1229984 was a clear outlier which inflated
causal estimates, indicates pleiotropy of this variant via its role in
alcohol metabolism. However, we found consistent evidence for a
causal effect of alcohol on oral and oropharyngeal cancer risk
when this variant was excluded from the analysis.
While we used a large number of genetic variants to serve as
stronger instruments for both smoking and alcohol, these variants
have not all been well characterised and indeed some of the top
loci have been previously associated with other risky beha-
viours13. Therefore, additional analyses to evaluate the causal
effects of risk tolerance and lifetime number of sexual partners on
oral/oropharyngeal cancer were conducted. While there was no
strong evidence for a causal effect of risk tolerance more gen-
erally, an effect of lifetime number of sexual partners was
observed, specific only to oropharyngeal cancer risk. This effect is
likely mediated through HPV and thought to be sexually
transmitted4,5. While further work is required to investigate this
effect of HPV status among oropharyngeal sites, it is unlikely to
have substantially biased the MR estimates for smoking and
alcohol, since no effect of lifetime number of sexual partners was
observed in relation to oral cavity cancer risk, whereas similar
effect estimates were observed in relation to alcohol and smoking.
Finally, as most participants in the GAME-ON network were of
European or North American decent, with only 10.8% from
South America, more work is required to determine if our results
translate to other ancestry groups.
In conclusion, this study used both univariable and multi-
variable MR analyses to demonstrate an independent causal effect
for both smoking and alcohol on oral and oropharyngeal cancer
risk. In particular, we observed large effects for alcohol in our
multivariable MR analysis, which suggests the possibility that
previous observational estimates for alcohol may have been
underestimated. However, these cannot be directly compared
given the differences in the methodological approaches and
interpretation of estimates. Further work using individual-level
data could provide more robust evidence for a synergistic effect
and the carcinogenic role of acetaldehyde. Findings from this
study add to a growing body of evidence from MR studies sur-
rounding the harmful effects of alcohol consumption34 and
should be used to guide public health messages regarding the
harms of even moderate drinking.
Methods
Univariable and multivariable Mendelian randomisation were applied using
summary-level genetic data from the GWAS and Sequencing Consortium of
Alcohol and Nicotine use (GSCAN)9, the UK Biobank study12,13, and a GWAS of
oral and oropharyngeal cancer conducted by the Genetic Associations and
Mechanisms in Oncology (GAME-ON) Network30, in a two-sample MR frame-
work35. Mendelian randomisation is an approach which uses genetic variants as
instruments to obtain estimates for the causal effect of these risk factors on disease
outcomes. Three assumptions must be satisfied to ensure an MR study is valid
which include: (1) genetic variants should be robustly associated with the risk
factor of interest (i.e., the relevance assumption), (2) there are no confounders of
the genetic variants-outcome association (the independence assumption) and (3)
the exclusion restriction assumption. For further detail on the terms used in this
study please read the Mendelian randomisation dictionary36.
Summary-level data from GSCAN and UK Biobank. Summary-level genome-
wide association studies were obtained for alcohol consumption (drinks per week,
n= 941,280) and smoking initiation (a binary phenotype indicating whether an
individual had ever smoked regularly) (n= 1,232,091) from the GSCAN study9.
The comprehensive smoking index (CSI) was derived by Wootton et al in the UK
Biobank (n= 462,690)12. This included information on smoking duration, heavi-
ness and cessation, which were combined into a lifetime smoking index along with
a simulated half-life (τ) constant. Summary-level GWAS data were obtained for
this phenotype in the UK Biobank12.
Summary-level data from GAME-ON. GWAS was performed on 6,034 HNSCC
cases and 6,585 controls from 12 studies which were part of the GAME-ON
network30. Cancer cases comprised the following ICD-10 codes: oral cavity
(C02.0–C02.9, C03.0–C03.9, C04.0–C04.9 and C05.0–C06.9) and oropharynx
(C01.9, C02.4 and C09.0–C10.9). The study population included participants from
Europe (45.3%), North America (43.9%) and South America (10.8%). Details of the
studies included, as well as the genotyping and imputation performed are
published30,37.
Univariable Mendelian randomisation. To assess causal effects of smoking and
alcohol consumption, we identified 60 single nucleotide polymorphisms (SNPs) for
alcohol consumption and 176 SNPs for smoking initiation reaching genome-wide
significance (p < 5 × 10−8) in the GSCAN GWAS which were present in the
GAME-ON GWAS (Supplementary Data 1, Supplementary Data 2). We also
identified 108 independent SNPs associated with the CSI at p < 5 × 10−8 in the UK
Biobank which were present in the GAME-ON GWAS (Supplementary Data 1,
Supplementary Data 2).
Instrument strength was determined by the magnitude and precision of
association of the genetic instruments with the risk factor, which was considered to
be sufficient if the corresponding F-statistic is >10. Linkage disequilibrium statistics
(r2) were evaluated to check the overlap between smoking initiation,
comprehensive smoking index and drinks per week loci using LDmatrix. All
pairwise correlations were low for the SNPs used to instrument smoking initiation
and drinks per week (r2 < 0.06) and those used to instrument comprehensive
smoking index and drinks per week (r2 < 0.07), with the exception of rs10236149
and rs6962772 which had an r2 of 0.743. For smoking initiation and comprehensive
smoking index, there were 6 duplicate SNPs and 11 SNP pairs which were in strong
LD (r2 > 0.8).
Two-sample MR analyses were conducted using the TwoSampleMR package
(version 0.5.5) in R (version 3.5.3), to extract the SNPs instrumenting the risk
factor from the oral/oropharyngeal cancer GWAS38. We next performed
harmonisation of the direction of effects between exposure and outcome
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associations, where palindromic SNPs were aligned when minor allele frequencies
(MAFs) were less than 0.3 or were otherwise excluded. SNP-specific Wald
estimates were calculated (SNP-outcome estimate divided by SNP-exposure
estimate) and an inverse variance weighted (IVW) random effects method applied
to meta-analyse these to obtain an estimate for the causal effect of the risk factor on
oral/oropharyngeal cancer risk.
To further assess the robustness of findings, we inspected the Cochran’s Q
statistic which assesses heterogeneity between individual genetic variants, and
which may indicate the presence of invalid instruments (e.g., due to horizontal
pleiotropy). Horizontal pleiotropy occurs when the genetic instruments are
associated with more than one independent biological pathway, which can result in
violation of the MR exclusion restriction assumption (i.e., the variable is not related
to the outcome other than via the risk factor of interest). First-order inverse-
variance weights were used to calculate both the IVW estimate and Cochran’s Q.
A random effects model was used in the presence of heterogeneity39. Scatter and
leave-one-out plots were produced to evaluate influential outliers and MR-PRESSO
(Mendelian Randomisation Pleiotropy RESidual Sum and Outlier) was used to
detect and correct for potential outliers (p < 0.05)40. MR-PRESSO is a unified
framework that evaluates genetic pleiotropy in a standard MR model. It attempts to
perform outlier removal in order to re-estimate the original exposure-outcome
relationship to reduce bias in MR estimates. The IVW method will provide an
unbiased estimate in the absence of horizontal pleiotropy or when horizontal
pleiotropy is balanced41. To account for pleiotropy, we compared results with three
other MR methods, which each make different assumptions about this: MR-
Egger42, weighted median43 and weighted mode44. MR-Egger can provide
unbiased estimates even when all SNPs in an instrument violate the exclusion
restriction assumption. Where there was evidence of violation of negligible
measurement error (NOME), assessed based on the I2 statistic, MR-Egger was
performed with simulation extrapolation (SIMEX) correction45. SIMEX relies on
simulation to estimate or reduce bias due to measurement error, considering
additional data sets with increasing measurement error variance. The weighted
median stipulates that at least 50% of the weight in the analysis stems from variants
that are valid instruments43, while the weighted mode requires that the largest
subset of instruments which identify the same causal effect to be valid
instruments44.
Stratification by cancer subsite. We further performed MR analysis for alcohol
and smoking with stratification by cancer subsite to evaluate potential hetero-
geneity in the causal effects. For this we used GWAS summary data on a subset of
2641 oropharyngeal cases and 2990 oral cavity cases from the 6034 HNSCC cases
in the GAME-ON Network GWAS used in the main analysis and the 6585
common controls30. A total of 954 individuals with HNSCC were excluded from
this analysis since these were cases of hypopharynx and overlapping cancers.
We also conducted further sensitivity analyses to estimate causal effects using
summary-level data obtained from the GWAS of smoking initiation and drinks per
week in GSCAN excluding UK Biobank and 23andMe, and summary-level data
obtained from a GWAS of smoking initiation38 and drinks per week13 in the UK
Biobank only.
Multivariable Mendelian randomisation. We next conducted two-sample mul-
tivariable MR analysis which included SNPs which were genome-wide significant
in either the GSCAN GWAS of alcohol consumption or the UK Biobank GWAS of
comprehensive smoking index. After excluding SNPs with a pairwise r2 greater
than 0.001, 168 independent SNPs were used in the analysis. To remove sample
overlap between the GWAS for alcohol consumption and CSI in the analysis, we
used summary-level data obtained from the GWAS of drinks per week in GSCAN,
excluding UK Biobank and 23andMe (n= 226,223) and summary-level data
obtained from the GWAS of CSI in the UK Biobank (n= 462,690). Both the IVW
and MR-Egger framework have been extended to estimate causal effects in mul-
tivariable MR analysis46,47, which was conducted using both the MVMR (version
0.2.0) and Mendelian Randomization48 (version 0.5.0) packages in R. We used
generalised versions of Cochran’s Q statistical tests to assess both instrument
strength and validity in the two-sample summary data setting, where the covar-
iance between the effects of the genetic variants on each exposure was fixed at zero
by using non-overlapping samples for each exposure. This was performed using the
MVMR package (version 0.2.0) in R.
Investigating other risky behaviours. We used 124 SNPs associated with risk
tolerance and 118 SNPs associated with lifetime number of sexual partners from
a large GWAS meta-analysis13. We performed MR using the same univariable
methods described in the main analysis and also evaluated the effects of these
exposures stratified by cancer subsite.
Statistics and reproducibility. All genome-wide association study (GWAS) data
used in this study had been previously replicated in independent datasets (see
respective GWAS studies)9,12,30. In our study, MG and RR independently repeated
all univariable and multivariable Mendelian randomisation analyses once, both
successfully obtaining the same conclusions.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
GWAS summary statistics for the SNPs used to estimate the causal effects of smoking
initiation, lifetime smoking and alcoholic drinks per week in this study are presented in
Supplementary Data 1 and 2. Full summary statistics for the GAME-ON GWAS have
been deposited in dbGAP (OncoArray: Oral and Pharynx Cancer; study accession
number: phs001202.v1.p1)30. Published data from this study can also be found in:
Lesseur, C. et al. Genome-wide association analyses identify new susceptibility loci for
oral cavity and pharyngeal cancer. Nat Genet. 48, 1544-1550 (2016)30. Smoking initiation
and alcohol consumption data (GSCAN study) are published in: Liu, M. Z. et al.
Association studies of up to 1.2 million individuals yield new insights into the genetic
aetiology of tobacco and alcohol use. Nat Genet. 51, 237 (2019)9. Comprehensive
smoking index (CSI) data is published in: Wootton, R. E. et al. Evidence for causal effects
of lifetime smoking on risk for depression and schizophrenia: a Mendelian
randomisation study. Psychol Med, 1–9 (2019)12. UK Biobank approval was given for this
project (ID 40644-Investigating aetiology, associations and causality in diseases of the
head and neck). A copy of the data generated in this this analysis is available at: https://
github.com/rcrichmond/smoking_alcohol_headandneckcancer49
Code availability
Two-sample MR analyses were conducted using the TwoSampleMR package (version
0.5.5) in R (version 3.5.3). Multivariable MR analysis was conducted using both the
MVMR (version 0.2.0) and MendelianRandomization (version 0.5.0)48 packages in R. A
copy of the code used in this this analysis is available at: https://github.com/rcrichmond/
smoking_alcohol_headandneckcancer49
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